9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts

MLA

Jamie M. Aye, et al. “9-Cis-UAB30, a Novel Rexinoid Agonist, Decreases Tumorigenicity and Cancer Cell Stemness of Human Neuroblastoma Patient-Derived Xenografts.” Translational Oncology, vol. 14, no. 1, Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....55e0ffc188566ee79402dd188357b638&authtype=sso&custid=ns315887.

APA

Jamie M. Aye, Raoud Marayati, Laura L. Stafman, Elizabeth A. Beierle, Adele P. Williams, Laura V. Bownes, Colin H. Quinn, Venkatram R. Atigadda, Karina J. Yoon, & Jerry E. Stewart. (2021). 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts. Translational Oncology, 14(1).

Chicago

Jamie M. Aye, Raoud Marayati, Laura L. Stafman, Elizabeth A. Beierle, Adele P. Williams, Laura V. Bownes, Colin H. Quinn, Venkatram R. Atigadda, Karina J. Yoon, and Jerry E. Stewart. 2021. “9-Cis-UAB30, a Novel Rexinoid Agonist, Decreases Tumorigenicity and Cancer Cell Stemness of Human Neuroblastoma Patient-Derived Xenografts.” Translational Oncology 14 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....55e0ffc188566ee79402dd188357b638&authtype=sso&custid=ns315887.